Markets

GW Pharmaceuticals (GWPH) Jumps: Stock Rises 6.6% - Tale of the Tape

GW Pharmaceuticals plc ( GWPH ) was a big mover last session, as the company saw its shares rise by roughly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained almost 30% since Feb 21.

This medical products company has seen one positive and one negative estimate revision over the last 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for GW Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.

GW Pharmaceuticals has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the same industry include Enzymotec Ltd. ( ENZY ), Covidien plc ( COV ) and SurModics, Inc. ( SRDX ). While Enzymotec holds a Zacks Rank #1 (Strong Buy), Covidien and SurModics carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

COVIDIEN PLC (COV): Free Stock Analysis Report

ENZYMOTEC LTD (ENZY): Free Stock Analysis Report

GW PHARMA-ADR (GWPH): Free Stock Analysis Report

SURMODICS (SRDX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

SRDX

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More